Time-resolved analysis of Staphylococcus aureus invading the endothelial barrier

Autor: Harita Yedavally, Anna Salvati, Elisa J M Raineri, Jan Maarten van Dijl
Přispěvatelé: University of Groningen, Nanomedicine & Drug Targeting, Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Nanotechnology and Biophysics in Medicine (NANOBIOMED), Microbes in Health and Disease (MHD), Translational Immunology Groningen (TRIGR)
Jazyk: angličtina
Rok vydání: 2020
Předmět:
staphylococcus aureus
Microbiology (medical)
endothelium
Endothelium
media_common.quotation_subject
Cells
Immunology
Infectious and parasitic diseases
RC109-216
Methicillin-Resistant Staphylococcus aureus/pathogenicity
Microscopy
Electron/methods

Umbilical Veins/cytology
medicine.disease_cause
Microbiology
Staphylococcus aureus/classification
Flow cytometry
03 medical and health sciences
medicine
Humans
Cytoplasm/microbiology
Internalization
Pathogen
Cells
Cultured

030304 developmental biology
media_common
0303 health sciences
Microscopy
Cultured
biology
medicine.diagnostic_test
030306 microbiology
Electron/methods
invasion
biology.organism_classification
intracellular
Flow Cytometry/methods
3. Good health
Endothelial stem cell
Infectious Diseases
medicine.anatomical_structure
Staphylococcus aureus
Host-Pathogen Interactions
mrsa
Parasitology
Endothelial Cells/microbiology
Intracellular
Bacteria
Zdroj: Virulence, 11(1), 1623-1639. Taylor & Francis Group
Virulence, Vol 11, Iss 1, Pp 1623-1639 (2020)
Virulence
ISSN: 2150-5594
Popis: Staphylococcus aureus is a leading cause of infections world-wide. Once this pathogen has reached the bloodstream, it can invade different parts of the human body by crossing the endothelial barrier. Infected endothelial cells may be lysed by bacterial products, but the bacteria may also persist intracellularly, where they are difficult to eradicate with antibiotics and cause relapses of infection. Our present study was aimed at investigating the fate of methicillin resistant S. aureus (MRSA) isolates of the USA300 lineage with different epidemiological origin inside endothelial cells. To this end, we established two in vitro infection models based on primary human umbilical vein endothelial cells (HUVEC), which mimic conditions of the endothelium when infection occurs. For comparison, the laboratory strain S. aureus HG001 was used. As shown by flow cytometry and fluorescence- or electron microscopy, differentiation of HUVEC into a cell barrier with cell-cell junctions sets limits to the rates of bacterial internalization, the numbers of internalized bacteria, the percentage of infected cells, and long-term intracellular bacterial survival. Clear strain-specific differences were observed with the HG001 strain infecting the highest numbers of HUVEC and displaying the longest intracellular persistence, whereas the MRSA strains reproduced faster intracellularly. Nonetheless, all internalized bacteria remained confined in membrane-enclosed LAMP-1-positive lysosomal or vacuolar compartments. Once internalized, the bacteria had a higher propensity to persist within the differentiated endothelial cell barrier, probably because internalization of lower numbers of bacteria was less toxic. Altogether, our findings imply that intact endothelial barriers are more likely to sustain persistent intracellular infection.
Databáze: OpenAIRE